{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:35:38Z","timestamp":1781768138235,"version":"3.54.5"},"reference-count":88,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_175561\/1"],"award-info":[{"award-number":["310030_175561\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hochschulstiftung der Universit\u00e4t Bern","award":["20\/2020"],"award-info":[{"award-number":["20\/2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Erythropoietin (Epo) is the critical hormone for erythropoiesis. In adults, Epo is mainly produced by a subset of interstitial fibroblasts in the kidney, with minor amounts being produced in the liver and the brain. In this study, we used the immortalized renal interstitial fibroblast cell line FAIK F3-5 to investigate the ability of the bioactive sphingolipid sphingosine 1-phosphate (S1P) to stimulate Epo production and to reveal the mechanism involved. Stimulation of cells with exogenous S1P under normoxic conditions (21% O2) led to a dose-dependent increase in Epo mRNA and protein levels and subsequent release of Epo into the medium. S1P also enhanced the stabilization of HIF-2\u03b1, a key transcription factor for Epo expression. S1P-stimulated Epo mRNA and protein expression was abolished by HIF-2\u03b1 mRNA knockdown or by the HIF-2 inhibitor compound 2. Furthermore, the approved S1P receptor modulator FTY720, and its active form FTY720-phosphate, both exerted a similar effect on Epo expression as S1P. The effect of S1P on Epo was antagonized by the selective S1P1 and S1P3 antagonists NIBR-0213 and TY-52156, but not by the S1P2 antagonist JTE-013. Moreover, inhibitors of the classical MAPK\/ERK, the p38-MAPK, and inhibitors of protein kinase (PK) C and D all blocked the effect of S1P on Epo expression. Finally, the S1P and FTY720 effects were recapitulated in the Epo-producing human neuroblastoma cell line Kelly, suggesting that S1P receptor-dependent Epo synthesis is of general relevance and not species-specific. In summary, these data suggest that, in renal interstitial fibroblasts, which are the primary source of plasma Epo, S1P1 and 3 receptor activation upregulates Epo under normoxic conditions. This may have a therapeutic impact on disease situations such as chronic kidney disease, where Epo production is impaired, causing anemia, but it may also have therapeutic value as Epo can mediate additional tissue-protective effects in various organs.<\/jats:p>","DOI":"10.3390\/ijms22179467","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T21:59:45Z","timestamp":1630447185000},"page":"9467","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["S1P Stimulates Erythropoietin Production in Mouse Renal Interstitial Fibroblasts by S1P1 and S1P3 Receptor Activation and HIF-2\u03b1 Stabilization"],"prefix":"10.3390","volume":"22","author":[{"given":"Redona","family":"Hafizi","sequence":"first","affiliation":[{"name":"Institute of Pharmacology, University of Bern, Inselspital, INO-F, CH-3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faik","family":"Imeri","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, University of Bern, Inselspital, INO-F, CH-3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7592-4839","authenticated-orcid":false,"given":"Roland H.","family":"Wenger","sequence":"additional","affiliation":[{"name":"Institute of Physiology, University of Z\u00fcrich, CH-8057 Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1615-5691","authenticated-orcid":false,"given":"Andrea","family":"Huwiler","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, University of Bern, Inselspital, INO-F, CH-3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,31]]},"reference":[{"key":"ref_1","unstructured":"Centers for Disease Control and Prevention (2019). Chronic Kidney Disease in the United States, 2019, US Department of Health and Human Services, Centers for Disease Control and Prevention."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00467-007-0524-0","article-title":"Mechanisms of progression of chronic kidney disease","volume":"22","author":"Fogo","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bbadis.2013.02.010","article-title":"Renal epithelial injury and fibrosis","volume":"1832","author":"Kaissling","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1017\/S1368980008002401","article-title":"Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993\u20132005","volume":"12","author":"McLean","year":"2009","journal-title":"Public Health Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"992","DOI":"10.7326\/0003-4819-111-12-992","article-title":"Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial","volume":"111","author":"Eschbach","year":"1989","journal-title":"Ann. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.semnephrol.2006.06.001","article-title":"Pathogenesis of renal anemia","volume":"26","author":"Nangaku","year":"2006","journal-title":"Semin. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/cphy.c100075","article-title":"Erythropoietin","volume":"1","author":"Wenger","year":"2011","journal-title":"Compr. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1073\/pnas.0630444100","article-title":"Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling","volume":"100","author":"Calvillo","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/01.ASN.0000135059.67385.5D","article-title":"Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion","volume":"15","author":"Sharples","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.coph.2006.01.003","article-title":"Novel applications of recombinant erythropoietin","volume":"6","author":"Sharples","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1124\/jpet.104.073197","article-title":"Erythropoietin reduces the development of experimental inflammatory bowel disease","volume":"311","author":"Cuzzocrea","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0014-2999(00)00466-0","article-title":"Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation","volume":"401","author":"Calapai","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1073\/pnas.042693799","article-title":"Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury","volume":"99","author":"Celik","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.shk.00001276869.21260.9d","article-title":"Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia","volume":"22","author":"Abdelrahman","year":"2004","journal-title":"Shock"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ndt\/gfg547","article-title":"Erythropoietin protects against ischaemic acute renal injury","volume":"19","author":"Vesey","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1442-2042.2011.02920.x","article-title":"Renoprotective effect of erythropoietin in ischemia\/reperfusion injury: Possible roles of the Akt\/endothelial nitric oxide synthase-dependent pathway","volume":"19","author":"Oba","year":"2012","journal-title":"Int. J. Urol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ki.2013.118","article-title":"Erythropoietin attenuates acute kidney dysfunction in murine experimental sepsis by activation of the \u03b2-common receptor","volume":"84","author":"Coldewey","year":"2013","journal-title":"Kidney Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11596-021-2370-x","article-title":"Carbamylated Erythropoietin Alleviates Kidney Damage in Diabetic Rats by Suppressing Oxidative Stress","volume":"41","author":"Dang","year":"2021","journal-title":"Curr. Med. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2015.02.005","article-title":"Flipping the molecular switch for innate protection and repair of tissues: Long-lasting effects of a non-erythropoietic small peptide engineered from erythropoietin","volume":"151","author":"Collino","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1172\/JCI113363","article-title":"Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney","volume":"81","author":"Lacombe","year":"1988","journal-title":"J. Clin. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ki.2008.687","article-title":"Nonrenal regulation of EPO synthesis","volume":"75","author":"Weidemann","year":"2009","journal-title":"Kidney Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.blre.2012.12.003","article-title":"Regulation of erythropoiesis by hypoxia-inducible factors","volume":"27","author":"Haase","year":"2013","journal-title":"Blood Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/BF01936936","article-title":"Role of erythropoietin in adaptation to hypoxia","volume":"46","author":"Scholz","year":"1990","journal-title":"Experientia"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1113\/jphysiol.2010.195057","article-title":"Regulation of erythropoietin production","volume":"589","author":"Jelkmann","year":"2011","journal-title":"J. Physiol."},{"key":"ref_26","first-page":"272","article-title":"Thyroid hormones enhance hypoxia-induced erythropoietin production in vitro","volume":"22","author":"Fandrey","year":"1994","journal-title":"Exp. Hematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1182\/blood.V96.9.3265","article-title":"Retinoic acid stimulates erythropoietin gene transcription in embryonal carcinoma cells through the direct repeat of a steroid\/thyroid hormone receptor response element half-site in the hypoxia-response enhancer","volume":"96","author":"Kambe","year":"2000","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.matbio.2018.01.006","article-title":"Sphingolipid signaling in renal fibrosis","volume":"68\u201369","author":"Huwiler","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1159\/000350093","article-title":"Sphingosine 1-phosphate in renal diseases","volume":"31","author":"Koch","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2174\/0929867324666170112114525","article-title":"Sphingolipids in Genetic and Acquired Forms of Chronic Kidney Diseases","volume":"24","author":"Ueda","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.prostaglandins.2004.09.010","article-title":"Sphingosine kinases, sphingosine-1-phosphate and sphingolipidomics","volume":"77","author":"Maceyka","year":"2005","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00210-007-0132-3","article-title":"Regulation and functional roles of sphingosine kinases","volume":"374","author":"Alemany","year":"2007","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbalip.2012.07.022","article-title":"Sphingosine-1-phosphate: A Janus-faced mediator of fibrotic diseases","volume":"1831","author":"Schwalm","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/bcpt.12103","article-title":"Targeting the sphingosine kinase\/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases","volume":"114","author":"Schwalm","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1042\/bst0311216","article-title":"Exogenous and intracellularly generated sphingosine 1-phosphate can regulate cellular processes by divergent pathways","volume":"31","author":"Spiegel","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI76369","article-title":"Emerging biology of sphingosine-1-phosphate: Its role in pathogenesis and therapy","volume":"125","author":"Proia","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ki.2009.297","article-title":"Transforming growth factor-\u03b22 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-\u03b22 by impeding CTGF expression","volume":"76","author":"Ren","year":"2009","journal-title":"Kidney Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.matbio.2021.05.003","article-title":"Loss of sphingosine kinase 2 enhances Wilm\u2019s tumor suppressor gene 1 and nephrin expression in podocytes and protects from streptozotocin-induced podocytopathy and albuminuria in mice","volume":"98","author":"Imeri","year":"2021","journal-title":"Matrix Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.ajpath.2017.06.017","article-title":"Sphingosine Kinase-2 Deficiency Ameliorates Kidney Fibrosis by Up-Regulating Smad7 in a Mouse Model of Unilateral Ureteral Obstruction","volume":"187","author":"Schwalm","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1681\/ASN.2016030306","article-title":"Sphingosine Kinase 2 Deficiency Attenuates Kidney Fibrosis via IFN-\u03b3","volume":"28","author":"Bajwa","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ghosh, M., Thangada, S., Dasgupta, O., Khanna, K.M., Yamase, H.T., Kashgarian, M., Hla, T., Shapiro, L.H., and Ferrer, F.A. (2018). Cell-intrinsic sphingosine kinase 2 promotes macrophage polarization and renal inflammation in response to unilateral ureteral obstruction. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194053"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biocel.2017.07.011","article-title":"Sphingosine kinase 1 protects renal tubular epithelial cells from renal fibrosis via induction of autophagy","volume":"90","author":"Du","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"109881","DOI":"10.1016\/j.cellsig.2020.109881","article-title":"Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis","volume":"79","author":"Schwalm","year":"2021","journal-title":"Cell. Signal."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0003-9861(02)00526-X","article-title":"Regulatory role of sphingomyelin metabolites in hypoxia-induced vascular smooth muscle cell proliferation","volume":"408","author":"Yun","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.bbrc.2008.01.132","article-title":"Sphingosine kinase-1 is a hypoxia-regulated gene that stimulates migration of human endothelial cells","volume":"368","author":"Schwalm","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1074\/jbc.M708241200","article-title":"Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2","volume":"283","author":"Anelli","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1158\/0008-5472.CAN-08-0917","article-title":"Sphingosine kinase 1: A new modulator of hypoxia inducible factor 1\u03b1 during hypoxia in human cancer cells","volume":"68","author":"Ader","year":"2008","journal-title":"Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/B978-0-12-394274-6.00005-4","article-title":"Hypoxia, therapeutic resistance, and sphingosine 1-phosphate","volume":"117","author":"Cuvillier","year":"2013","journal-title":"Adv. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kalhori, V., Kemppainen, K., Asghar, M.Y., Bergelin, N., Jaakkola, P., and Tornquist, K. (2013). Sphingosine-1-Phosphate as a Regulator of Hypoxia-Induced Factor-1\u03b1 in Thyroid Follicular Carcinoma Cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066189"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"13803","DOI":"10.18632\/oncotarget.3144","article-title":"Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer","volume":"6","author":"Ader","year":"2015","journal-title":"Oncotarget"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1038\/oncsis.2016.13","article-title":"Essential role for SphK1\/S1P signaling to regulate hypoxia-inducible factor 2\u03b1 expression and activity in cancer","volume":"5","author":"Bouquerel","year":"2016","journal-title":"Oncogenesis"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.kint.2018.08.043","article-title":"Generation of renal Epo-producing cell lines by conditional gene tagging reveals rapid HIF-2 driven Epo kinetics, cell autonomous feedback regulation, and a telocyte phenotype","volume":"95","author":"Imeri","year":"2019","journal-title":"Kidney Int."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1038\/s41598-019-47766-5","article-title":"An immortalized cell line derived from renal erythropoietin-producing (REP) cells demonstrates their potential to transform into myofibroblasts","volume":"9","author":"Sato","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1021\/bi0265022","article-title":"Glycosylation of erythropoietin affects receptor binding kinetics: Role of electrostatic interactions","volume":"41","author":"Darling","year":"2002","journal-title":"Biochemistry"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/01.ASN.0000017223.49823.2A","article-title":"Expression of hypoxia-inducible factor-1\u03b1 and -2\u03b1 in hypoxic and ischemic rat kidneys","volume":"13","author":"Rosenberger","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00277-007-0359-6","article-title":"Contribution of HIF-1\u03b1 or HIF-2\u03b1 to erythropoietin expression: In vivo evidence based on chromatin immunoprecipitation","volume":"87","author":"Yeo","year":"2008","journal-title":"Ann. Hematol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ki.2009.460","article-title":"Hypoxia-inducible factor-2\u03b1-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization","volume":"77","author":"Paliege","year":"2010","journal-title":"Kidney Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nchembio.1185","article-title":"Allosteric inhibition of hypoxia inducible factor-2 with small molecules","volume":"9","author":"Scheuermann","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.chembiol.2012.07.016","article-title":"A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis","volume":"19","author":"Quancard","year":"2012","journal-title":"Chem. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0008-6363(03)00260-8","article-title":"Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2","volume":"58","author":"Ohmori","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1124\/mol.109.061481","article-title":"Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: Investigation based on a new S1P3 receptor antagonist","volume":"77","author":"Murakami","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0006-291X(91)91734-T","article-title":"Inhibition of erythropoietin production by phorbol ester is associated with down-regulation of protein kinase C-\u03b1 isoenzyme in hepatoma cells","volume":"179","author":"Jelkmann","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1432-1033.1994.tb20057.x","article-title":"Distinct signaling pathways mediate phorbol-ester-induced and cytokine-induced inhibition of erythropoietin gene expression","volume":"226","author":"Fandrey","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00374666","article-title":"Hypoxia-induced accumulation of erythropoietin mRNA in isolated hepatocytes is inhibited by protein kinase C","volume":"426","author":"Eckardt","year":"1994","journal-title":"Pflugers Arch."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"C1204","DOI":"10.1152\/ajpcell.1992.262.5.C1204","article-title":"Phorbol ester inhibits erythropoietin production in human hepatoma cells (Hep G2)","volume":"262","author":"Kurtz","year":"1992","journal-title":"Am. J. Physiol."},{"key":"ref_66","first-page":"239","article-title":"Protein kinase C and mammary cell differentiation: Involvement of protein kinase C \u03b1 in the induction of \u03b2-casein expression","volume":"5","author":"Marte","year":"1994","journal-title":"Cell Growth Differ."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0006-291X(05)81432-9","article-title":"RO 31-8220 and RO 31-7549 show improved selectivity for protein kinase C over staurosporine in macrophages","volume":"181","author":"Dieter","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/1535-7163.MCT-09-1145","article-title":"A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo","volume":"9","author":"Harikumar","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"188496","DOI":"10.1016\/j.bbcan.2020.188496","article-title":"Evaluating the current status of protein kinase C (PKC)-protein kinase D (PKD) signalling axis as a novel therapeutic target in ovarian cancer","volume":"1875","author":"Tyagi","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.3324\/haematol.2019.236406","article-title":"Distal and proximal hypoxia response elements cooperate to regulate organ-specific erythropoietin gene expression","volume":"105","author":"Orlando","year":"2020","journal-title":"Haematologica"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2016.01.002","article-title":"Erythropoeitin Signaling in Macrophages Promotes Dying Cell Clearance and Immune Tolerance","volume":"44","author":"Luo","year":"2016","journal-title":"Immunity"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1182\/blood-2010-02-270322","article-title":"Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia","volume":"116","author":"Kapitsinou","year":"2010","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"32631","DOI":"10.1074\/jbc.274.46.32631","article-title":"p42\/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) and enhance the transcriptional activity of HIF-1","volume":"274","author":"Richard","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_74","first-page":"4873","article-title":"The Kaposi\u2019s sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1\u03b1","volume":"60","author":"Sodhi","year":"2000","journal-title":"Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.4161\/cc.26930","article-title":"CDK1 stabilizes HIF-1\u03b1 via direct phosphorylation of Ser668 to promote tumor growth","volume":"12","author":"Warfel","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"38944","DOI":"10.1074\/jbc.M110.160325","article-title":"Plk3 functions as an essential component of the hypoxia regulatory pathway by direct phosphorylation of HIF-1\u03b1","volume":"285","author":"Xu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1128\/MCB.00015-07","article-title":"Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1\u03b1 and mediates its destabilization in a VHL-independent manner","volume":"27","author":"Flugel","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/jcb.25314","article-title":"Protein Kinase C Isoforms Differentially Regulate Hypoxia-Inducible Factor-1\u03b1 Accumulation in Cancer Cells","volume":"117","author":"Kim","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Xia, J., Ozaki, I., Matsuhashi, S., Kuwashiro, T., Takahashi, H., Anzai, K., and Mizuta, T. (2019). Mechanisms of PKC-Mediated Enhancement of HIF-1\u03b1 Activity and its Inhibition by Vitamin K2 in Hepatocellular Carcinoma Cells. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20051022"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1096\/fj.04-1640fje","article-title":"Differentiating the functional role of hypoxia-inducible factor (HIF)-1\u03b1 and HIF-2\u03b1 (EPAS-1) by the use of RNA interference: Erythropoietin is a HIF-2\u03b1 target gene in Hep3B and Kelly cells","volume":"18","author":"Warnecke","year":"2004","journal-title":"FASEB J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00424-016-1829-2","article-title":"Erythropoietin production by PDGFR-\u03b2(+) cells","volume":"468","author":"Gerl","year":"2016","journal-title":"Pflugers Arch."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1113\/JP280572","article-title":"Regulation of glycolysis by the hypoxia-inducible factor (HIF): Implications for cellular physiology","volume":"599","author":"Kierans","year":"2021","journal-title":"J. Physiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/1535-7163.MCT-16-0167","article-title":"FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model","volume":"15","author":"Gstalder","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1096\/fj.201901734RR","article-title":"Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate","volume":"34","author":"Hait","year":"2020","journal-title":"FASEB J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.1176709","article-title":"Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate","volume":"325","author":"Hait","year":"2009","journal-title":"Science"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1159\/000322343","article-title":"FTY720-induced suicidal erythrocyte death","volume":"26","author":"Eberhard","year":"2010","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"eaax8050","DOI":"10.1126\/scisignal.aax8050","article-title":"A G protein-biased S1P1 agonist, SAR247799, protects endothelial cells without affecting lymphocyte numbers","volume":"13","author":"Poirier","year":"2020","journal-title":"Sci. Signal."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1111\/bcp.14632","article-title":"Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial","volume":"87","author":"Bergougnan","year":"2021","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/17\/9467\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:53:36Z","timestamp":1760165616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/17\/9467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":88,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["ijms22179467"],"URL":"https:\/\/doi.org\/10.3390\/ijms22179467","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,31]]}}}